Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022 Read more about Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022
Zai Lab Plants a Tree for Every Employee on Earth Day 2022 Read more about Zai Lab Plants a Tree for Every Employee on Earth Day 2022
Zai Lab to Present New Oncology Research at 2022 AACR Annual Meeting Read more about Zai Lab to Present New Oncology Research at 2022 AACR Annual Meeting
Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022 Read more about Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022
Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting Read more about Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer Read more about Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer
Zai Lab Statement on SEC Provisional Listing Matter Read more about Zai Lab Statement on SEC Provisional Listing Matter
Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021 Read more about Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021
Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China Read more about Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China